| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | — | -11.4% |
| Cost of Revenue | $717K | — | -7.0% |
| Gross Profit | $403K | — | -18.3% |
| R&D Expense | $582K | — | -24.6% |
| SG&A Expense | $1.5M | — | +7.7% |
| Pre-tax Income | -$1.7M | — | -2.9% |
| Net Income | -$1.7M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.3M | -15.8% | +67.1% |
| Short-term Investments | $43K | -1.2% | -0.8% |
| Accounts Receivable | $343K | -26.2% | +20.6% |
| Inventory | $891K | -7.3% | -27.0% |
| Current Assets | $10.8M | -16.1% | +48.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +12.0% |
| Financing Cash Flow | -$137K | — | -116.4% |
| -2.9% |
| EPS (Basic) | -$0.44 | — | +83.8% |
| EPS (Diluted) | -$0.44 | — | +83.8% |
| $13.4M |
| -14.2% |
| +27.7% |
| Current Liabilities | $1.6M | -15.5% | +8.3% |
| Total Liabilities | $1.8M | -17.5% | -14.5% |
| Stockholders' Equity | $11.6M | -13.7% | +38.1% |